Gene · 55922
NKRF: NFKB repressing factor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NKRF: NFKB repressing factor. Genes, record 55922. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55922
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15226 | NF-kappa-B-repressing factor | 690 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents55
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 55631 | O15226 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55632 | O15226 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4305 | O15226 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15389 | O15226 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4305 | O15226 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 32397 | O15226 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 32398 | O15226 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15389 | O15226 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15389 | O15226 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 32397 | O15226 | Espacenet |
1 to 10 of 55
See all 55 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants926
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NKRF papers | Newest fiscal year |
|---|---|---|---|
| P40OD010440 | Caenorhabditis Genetics Center | 26 | 2025 |
| P30DK036836 | Diabetes Research Center | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 4 | 2025 |
| T32DK007260 | Training Grant in Diabetes and Metabolism | 4 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 3 | 2025 |
| R01AG054215 | Homeostasis functions of SKN-1A/Nrf1 | 3 | 2025 |
| R35GM122610 | Signaling mechanisms that detect stress and maintain homeostasis | 3 | 2025 |
| T32HG000044 | Institutional Training Grant in Genome Science | 3 | 2025 |
| P30AG024827 | Pittsburgh Older Americans Independence Center | 2 | 2025 |
1 to 10 of 926Source NIH's project files
See all 926 nih grantsPapers1,288
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CHST1 Drives Immunotherapy Resistance in Triple-Negative Breast Cancer by Orchestrating an Immunosuppressive Microenvironment via the NKRF-CCL20-Macrophage Axis. | Adv Sci (Weinh) | 2026 | 42635979 | PubTator, text mining | PubMed |
| The Reproductive Toxicity of Microplastics: From Environmental Contamination to Organ Distribution and Reproductive Hazards. | Environ Toxicol | 2026 | 42528124 | PubTator, text mining | PubMed |
| Proteolytic activation of c-MYC facilitated by DOT1L. | Proc Natl Acad Sci U S A | 2026 | 42520114 | PubTator, text mining | PubMed |
| Hydroxylamine steers nitrogen metabolism toward dissimilatory nitrate reduction to ammonium by suppressing competitive denitrification. | Bioresour Technol | 2026 | 42398553 | PubTator, text mining | PubMed |
| Ribonuclease DIS3 delays aging and senescence by generating tRNA halves. | Nat Commun | 2026 | 42168172 | PubTator, text mining | PubMed |
| Cathepsin B protease mediates high population density-induced mutagenesis to drive genome evolution and competitive growth. | Nat Commun | 2026 | 42082483 | PubTator, text mining | PubMed |
| TRIM26-mediated NKRF degradation drives Osimertinib resistance through SNRPD2-dependent stress granule formation in lung adenocarcinoma. | Cell Death Dis | 2026 | 42026030 | PubTator, text mining | PubMed |
| Repurposing Hetrombopag for Multiple Myeloma by Targeting PNPO: A Celastrol-Inspired Approach. | Basic Clin Pharmacol Toxicol | 2026 | 41914238 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| Biochar enhances nitrogen removal capacity in sulfur-driven autotrophic denitrification at low temperatures: Performance evaluation, microbial structure analysis, and metabolic pathway reconstruction. | Bioresour Technol | 2026 | 41856334 | PubTator, text mining | PubMed |
1 to 10 of 1,288
See all 1,288 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55922
GET https://conductscience.org/api/genes/v1/55922/patents?page=2